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Surgical approaches for many tumours are often limited by blood loss, exposure and risk 
to vital anatomical structures; therefore, the standard of care for certain skull base 
tumours has become endoscopic transnasal resection. Other surgical disciplines often use 
cell salvage techniques, but review of the otolaryngology literature reveals very few case 
reports. General surgery procedures are often carried out in a contaminated field and 
concerns have been raised about its safety. 
 
This study investigates the value and safety of salvage-type autologous blood transfusion 
during the endoscopic resection of juvenile nasopharyngeal angiofibromas (JNA). 
 
Methods: 
Because JNA is a rare vascular nasal tumour, the study extended over a 3-year period to 
obtain adequate patient numbers. All patients undergoing endoscopic resection during 
this period were included in the population sample. Ten patients with JNA were 
identified and underwent embolization prior to endoscopic resection. In all cases the 




Homologous blood transfusion could be avoided in all cases and post-operative 
monitoring revealed no features of severe sepsis. Transient bacteraemia developed in two 
cases where a leukocyte filter was not used  
 
Conclusion:  
Perioperative cell saver utilization and autologous blood transfusion in endonasal JNA 
surgery is safe and its future use is promising. Homologous blood transfusion can be 
avoided by using this technique. The use of cell salvage allows for single stage surgery 
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New technological advances have made the endoscopic resection of skull base tumours 
possible, with reduced postoperative morbidity without compromising outcomes. The 
endoscopic resection may be impeded by factors such as blood loss, lack of adequate 
exposure and tumour proximity to vital anatomical structures. (1, 2, 3) 
 
There is insufficient data and limited research on the use of cell salvage during the 
endoscopic resection of benign vascular sinonasal tumours (4). Intraoperative cell salvage 
(PCS) techniques have however been used for over 25 years in trauma, orthopaedic, 
urological, liver transplant and cardiac surgery (4).  
 
Cell salvage techniques involve the (4): 
• Use of a leukocyte depletion filter (LDF) 
• Collection of concentrated red cells that are washed with normal saline prior to 
infusion 
• Use of a centrifuge to separate the components 
• Collection of blood intraoperatively  
 
 
Angiofibroma extending into nasopharynx & 
pterygopalatine fossa  




Cell Salvage advantages (5): 
• Often acceptable to members of the Jehovah Witness religious group 
• Burden on blood donation systems is reduced 
• Any blood lost during surgery is proportional to the blood available 
• Haemodilution is avoided 




The use of intraoperative cell salvage (PCS) overcomes homologous blood transfusion 
risks that include (6,7) 
• Postoperative infection 
• End-organ injury 
• Immunosuppression 
• Volume overload 
• Graft versus host disease 
• Allergic and febrile reactions  
 
The risk of transfusion-induced HIV and/or Hepatitis B or C during homologous blood 
transfusion is very low, but some infections occur frequently such as Epstein-Barr virus 
 Cell salvage machine  Cell salvage technique 
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(EBV) and cytomegalovirus (CMV). There has been insufficient research into the impact 




The investigation of the benefits of cell salvage during the endoscopic resection of 
sinonasal angiofibromas (JNA) would be valuable. A prospective study at Groote Schuur 
Hospital aims to reveal how this technique could:       
1. Enable total resection at the first procedure with a reduced need to abandon 
surgery because of blood loss. 
2. Reduce the routine use of homologous blood transfusion during JNA surgery 
a. With a reduced burden on blood donation systems 
b. With a reduced risk of transfusion complications 
3. Allow for safe surgery for Jehovah Witness patients. 
 
AIM & OBJECTIVES 
 
AIM  
This study aims to evaluate the use of cell salvage in endoscopic transnasal surgery for 
benign vascular tumours, such as JNA. Intraoperative cell salvage (PCS) has been 
extensively used in other surgical disciplines such as trauma, orthopaedic, urological, 
liver transplant and cardiac surgery. 
 
OBJECTIVES 
• To evaluate how allogeneic blood transfusion could be reduced by examining the 
evidence with regards to the efficacy of cell salvage  
• To examine the evidence on clinical outcomes after using PCS during surgery 
• To investigate the presence of bacteria in blood collected from the surgical field for 
autotransfusion 




RESEARCH DESIGN & METHODS 
 
Study Design 
This is a prospective study to investigate the use of intraoperative cell salvage and 
autologous blood transfusions in endonasal JNA surgery at Groote Schuur Hospital. 
 
Population and Sampling 
 
Population: 
The sample population will include patients with JNA who are undergoing endoscopic 
surgical resection and require cell saver blood transfusion. 
  
Sampling: 
1. The technician will collect blood from the cell saver unit and send it to the National 
Health Laboratory Service (NHLS) for microscopy, culture and sensitivities (MCS) 
2. Blood will be collected from each patient, who will then receive autologous blood 
rather than allogeneic blood 
3. Patients will be monitored for signs of infection postoperatively by routine methods 
such as pulse rate and temperature 
4. Patients’ medical records accessed for the following data: 
• Blood loss and volume of autologous blood transfused 
• Culture results 
• Any adverse reaction to the transfusion, such as fever or allergic reactions 
 
Sample size: 
The study will include all patients who undergo endoscopic resection of JNA. Because 
JNA is a rare vascular nasal tumour with only a few patients presenting to our unit per 









Only hospital folder numbers will be used during the collection, analysis and reporting of 
data to protect the identity of patients. 
 
Beneficence: 
Valuable information might be gleaned regarding the benefits of using PCS during the 
endoscopic resection of JNA. Cell salvage techniques could make surgery possible for 
Jehovah Witness patients and could avoid allogeneic blood transfusions.  
 
By examining the evidence of the efficacy of cell salvage, certain benefits may be 
determined.  The need for allogeneic blood transfusion may be reduced and clinical 
outcome may be improved. 
 
Non-maleficence:  
No patients will be subjected to harm from the procedures performed in this study. Most 
patients require blood transfusion during the resection of JNA (whether endoscopic or 
open techniques are used). By using cell saver techniques there is less risk of disease 
transmission and adverse reactions. 
 
Process of Obtaining Informed Consent and Assent: 
JNA is a vascular tumour only occurring in young adolescent males, usually before the 
age of 18 years. Consent will be obtained from every adolescent patient involved in this 
study, as well as from their parents. 
 
Stakeholder and reporting 
The results of the study will be reported back to the Division of Otolaryngology at Groote 
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A review of the English literature reveals few studies relating to the control of blood loss 
through the use of cell salvage during endoscopic sinonasal surgery. The role of cell 
salvage techniques within the contaminated surgical field is controversial as this was 
considered to be a contraindication during the early teaching of this subject. This has now 
been challenged. Due to safety concerns related to transfused blood products, surgeons 
have used allogeneic blood. There is a belief that there is very little risk from using 
allogeneic blood because a specialist laboratory screens the blood. Therefore, the risks of 
Hepatitis C and Human Immunodeficiency Virus (HIV) contamination of allogeneic 
blood are considered to be very low (1). However, these infections are prevalent in many 
developing countries and are a significant concern as health care services often do not 
meet the highest international standards and are often inadequately equipped.  
 
It is expensive to provide blood products that are safe and reliable and this influences 
costs related to using allogeneic blood (2). There have been more recent concerns relating 
to variant Creutzfeldt-Jakob disease, which have had a negative impact on blood 
transfusion services and the availability of blood and blood products. The criteria applied 
to donors that might have been exposed to this disease have become stricter.  
 
Within clinical practice, using allogeneic blood raises many issues, but specifically in 
Sub-Saharan Africa where infections such as malaria, syphilis, Hepatitis C, Hepatitis B 
and HIV are prevalent. There are many studies that have proven that blood products can 
transmit infection. Healthcare professionals also need to restrict the use of allogeneic 
blood as this is a limited resource despite effective screening in some areas. There are 
various factors in Sub-Saharan Africa that influence the supply of donated blood, such as 





The following table summarises how allogeneic blood received from a blood bank often 
causes complications that are commonly exposed (10) (SHOT report 2012).  
Table 1: SHOT report 2012 
Medical research has encouraged health professionals to reduce the use of allogeneic 
blood transfusions to overcome the problems associated with its high costs, blood 
shortages and blood safety by using new medical technologies. The surgical field has 
now widely adopted cell salvage as one of these new techniques. In the United Kingdom, 
Reaction  % of total adverse events 
Acute transfusion reactions  29 
Incorrect blood component transfused  25 
Handling and storage errors  13 
Anti-D events  13 
Inappropriate and unnecessary transfusion  7 
Haemolytic transfusion reactions  5 
Autologous transfusion reactions  3 
Transfusion-related acute lung injury (TRALI)  2 
Transfusion-associated circulatory overload  2 
ABO incompatibility  1 
Mortality  0.9 
Transfusion transmitted infections  0.6 
Post-transfusion purpura  0.1 
Transfusion-associated dyspnoea  0.1 
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surgical patients receive around half of the blood transfused, which justifies the need to 
adopt techniques that reduce perioperative allogeneic red cell transfusion (3). 
 
In 1881, Blundell was the first health professional to use autologous transfusion for 
patients with post-partum haemorrhage by using swabs soaked in blood that were then 
washed in saline. This mixture was re-infused into the patient, but high mortality often 
resulted. It was not until 1931 that this technology advanced when blood was re-infused 
directly to the patient from a haemothorax.  The first cell salvage device was developed 
in 1943 and collected blood by suction into a reservoir that removed the clots and 
subsequently passed the blood through a cloth. This technique forms the basis for later 
cell saver machines; devices were first available commercially in the 1960s.       
 
Intraoperative cell salvage blood transfusion has three stages:  The surgical field is used 
to collect blood; a double-lumen suction device is used to suction the blood; and 
heparinised saline is added. A filter is used when the mixture is pumped to a collection 
reservoir and then red blood cells are separated by centrifugation in a spinning container.        
 
Discarded components are transferred to the waste bag and the container retains the 
separated red blood cell component. The spinning centrifuge system has normal saline 
pumped inside and through the heavier red blood cell component. The residual waste 
products pass into the waste line. Waste products include plasma, free haemoglobin, cell 
debris and anticoagulant. Saline is then added to the remaining blood cells to achieve a 
haematocrit between 50% and 60% and after pumping it to a bag, the product is ready for 
transfusion (4). The surgical team decides whether to adopt cell salvage for patients intra-
operatively. Specific clinical situations could require adaptions if there is a possibility of 
significant unexpected bleeding (5).  
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Previous studies found that, when compared to blood from a blood bank, the function and 
morphology of red cells collected from cell salvage was of higher quality and retained 
normal membrane stability (6). Other studies have revealed that after re-transfusion, 
patients have a good survival rate, as stores of adenosine triphosphate and 2, 3-
diphosphoglycerate are higher in collected blood when compared with allogeneic blood 
(7). 
In 2009, guidelines were issued by the Association of Anaesthetists of Great Britain and 
Ireland, which highlighted issues for intraoperative cell salvage use. It included patients 
who decline transfusion of allogeneic blood, patients with unusual antibodies and blood 
types, patients that are at risk for bleeding, low initial haemoglobin, or estimated loss of 
blood of more than 20% of the patient’s blood volume, or more than 1000 ml (8). 
Findings from previous studies did not recommend using the cell saver in contaminated 
surgery, but more recent research has investigated microbiological contamination of 
salvaged blood to evaluate clinical effects. Microbiological contamination of salvaged 
blood during sterile procedures has an incidence of between 12.7% (9) and 33.3% (10) in 
previous studies, but no studies could be found on reviewing the literature on endonasal 
surgery (11). 
 
Kudo et al. carried out a survey of cell saver use in neurosurgical procedures, and the 
processed blood was subjected to microbiological analysis. The cell saver specimens 
were sent for MCS and both staphylococci and streptococci were cultured. The blood that 
was collected was not transfused (12).  
 
There is insufficient evidence of the effectiveness of using cell saver systems with 
patients for endonasal surgery from reviewing the English ENT literature, although this 
topic has been studied for maxillofacial surgery. Rohling et al. used a sample population 
of nine patients for their study, and found that bacteria grew on all cell saver red blood 
cell concentrates, which were mostly staphylococcus aureus and streptococcus viridans. 
However, the researchers did not document the degree of contamination. The findings 
revealed that patients had autologous blood transfused, which resulted in a rise in 
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cytokine levels and a transient bacteraemia. Correlation with clinical features did not 
suggest sepsis. Intraoperative antibiotics were given to all patients (13). There is general 
agreement that around the nasal and oral cavities, the quantity and species of bacteria 
varies, but research regarding PCS use in maxillofacial surgery provides practical insights 
into likely consequences of its use (14). 
 
 
Waters et al. used Bacillus fragilis, Pseudomonas aeruginosa, Staphylococcus aureus, and 
Escherichia coli to inoculate expired packed erythrocytes. They demonstrated that 
bacterial colony-forming units could be cleared by between 97.6% and 100%, when 
blood is subjected to a leukocyte filtration system and is washed (15). 
 
Cardiac surgery is the main field that has been studied. One study used a large sample 
population of 401 patients and routinely cultured samples of cell saver blood. The blood 
cultures were positive in 12.7% of cases. Most of these cases resulted in cultures that 
produced coagulase-negative staphylococci, meaning that contaminated blood was 
transfused back into the patient. It was however not associated with significant morbidity 
or mortality (16). 
 
Studies have examined the use of perioperative cell salvage in relatively contaminated 
areas. Yamada et al. (17) used PCS in 33 total abdominal hysterectomies that were 
contaminated with vaginal flora; 75% of the transfused units revealed contamination, but 
the findings indicated that the blood transfusions did not result in negative effects for 
patients (17). Another study of hollow viscous injury and trauma produced similar results 
(17). 
 
Antibiotic prophylaxis is mandatory for all surgery in contaminated fields, and cases 
mentioned earlier had all had prophylactic antibiotics (14). Forty patients formed a 
randomised control trial in a study by Wollinsky et al. (18) that were undergoing primary 
hip arthroplasty. These findings revealed that although the treatment arm showed no 




General guidelines for the use of cell salvage during surgery would include the following: 
1. A patient with significant red blood cell antibodies 
2. A Jehovah’s Witnesses patient requiring surgery where significant blood loss is 
anticipated 
3. When significant blood loss of more than 1000 mL is anticipated (19) 
 
The National Institute for Health and Clinical Excellence (NICE) issued a 
recommendation in April 2008 to endorse using autologous blood transfusion for cancer 
surgery, and particularly for cystectomy and prostatectomy (20). A Cochrane review 
recently showed that cell salvage did not result in adverse outcomes, and that when used 
it reduced transfusion rates.    
 
Recent findings by Catling et al. (21) suggested adding a leukocyte filter to the cell saver 
in gynaecologic malignancies, based on a sample of 50 patients with intraoperative 
presence of tumour cells that were undergoing surgery for ovarian, endometrial or 
cervical cancer. Samples of blood were taken from the cell saver re-transfusion bag 
before and after leukocyte filtration, the cell saver reservoir, the efferent tumour vein and 
the central venous line (21). Immunohistochemistry was used to identify tumour cells by 
using anti-cytokeratin antibodies against epithelial cells, and the findings revealed no 
tumour cells in the post-leukocyte filtration or effluent tumour vein samples, 34 of 50 cell 
saver reservoir samples and 2 of 50 central line samples.         
 
The American Association of Blood Banks (AABB) published ‘Standards for Perioperative 
Collection and Transfusion’ to create guidelines for carrying out intraoperative cell 
salvage that should establish a safe standard of care (22). When blood is subjected to a 
leukocyte filtration system and washed, Waters et al. found that 97.6% to 100 % of 
bacterial colony-forming units could be cleared (22). 
 
Researchers have continued to question the significance of transfused cell saver blood 
causing bacteraemia, and whether this could be more significant than when surgery 
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causes a transient bacteraemia. Cardiac surgery provides the most evidence relating to 
humans, as this discipline deals with more surgical cases requiring the use of cell saver 
blood. Samples of cell saver blood were routinely cultured in a large study of 401 
patients, and in 12.7% of this population sample, blood cultures were positive, where 
most cultures grew coagulase-negative staphylococci. Patients had received contaminated 
blood in these cases, because culture results were received after transfusion, but the 
findings reported that no significant mortality or morbidity was linked to the transfusion, 
even though bacteria was observed in over 90% of contaminated bags (23). 
The mechanism of leukocyte reduction by LDF is inadequately understood. It is widely 
accepted that centrifugal effects are the mechanisms to eliminate bacteria with cell saver 
methods. Erythrocytes have a thickness of 2 lm and a diameter of 8 lm, but the size of 
bacteria could vary from 1 – 2 lm in length and 0.5 – 1 lm in diameter. These 
measurements suggest that bacterial removal mechanisms cannot depend on size alone, 
but would be more dependent on adhesive characteristics of the filter, such as the surface 
structure of the material used in the filter, wettability and surface charge (24, 25).  
The use of leukodepletion filters to remove bacteria has revealed four potential 
mechanisms (24–25) 
1. Filtration enhanced by complement-mediated bacterial killing
2. The filter retains bacteria by adherence to leukocyte surfaces
3. The disintegration of cells and deformability of infected cells in the filter
4. The filter media removes the bacteria directly
In research that examined the capacity of LDFs to extract tumour cells from salvaged 
blood, 50 gynae-oncology surgery patients formed an observational study, and samples of 
blood were collected after passing through an LDF, from the cell saver before and after 
processing and before the operation. The results revealed viable tumour cells that were 
observed in 62% of samples after processing, in 68% of cell saver reservoirs before 
processing and in 4% of preoperative samples. No tumour cells were found when 
21 
salvaged blood had been passed through an LDF, although tumour cell fragments were 
revealed, but these were not able to cause metastases.      
 
A study in the USA of a large teaching hospital to analyse associated costs of cell salvage 
and allogeneic blood transfusion used a comparison of average costs of a unit of cell 
salvage blood and allogeneic blood, and discovered that an average saving of $110.54 per 
unit could be achieved by using cell salvage (24, 25). 
 
 
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA (JNA) 
 
JNA is a rare, benign, vascular head and neck tumour (0.5%)  found in adolescent males 
(26,27). It originates in the posterior nasal cavity / nasopharynx. JNA are noted for their 
progressive and locally invasive spread and they often result in degrees of morbidity that 
are significant, and usually related to massive haemorrhage or intracranial extension. 
Hippocrates first described JNA in the 5th Century BC in conjunction with nasal polyps 
(28). 
Demographics 
JNA occurs in teenage males between 10 and 25 years of age but most cases are 
identified between 14 and 15 years of age (29). It demonstrates a very slow rate of 
growth (are indolent), and patients are often symptomatic for at least 6 to 12 months 
before diagnosis. When diagnosed, around 70% of these young male patients have 
already reached stage II presentation (29).  
Origins and pathophysiology 
 
JNA normally originates from the internal maxillary artery, although this tumour can also 
originate from the internal, external and common carotid arteries, as well as the 
ascending pharyngeal artery. The exact original site of JNA lack widespread agreement, 
but most findings support the view that JNA is involved at the posterolateral nasal wall at 
the sphenopalatine foramen. 
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There is insufficient clarity regarding the 
pathophysiology of JNA origin. The tumours are 
normally located at the superior margin of the 
sphenopalatine foramen. Some argue that the     
underlying mechanism of JNA is associated with 
the embryologic chondrocartilage of the skull 
bones (30). The development of JNA could also be 
associated with the pituitary androgen-oestrogen 
axis (30), because on some JNA cells, androgen and oestrogen receptors have been 
observed (31). Other studies have indicated that insulin-like growth-factor-2, 
transforming growth-factor beta-1 or vascular endothelial growth-factor receptor-2 could 
have a role (32). Research studies have also proposed that JNA could be a vascular 
hamartoma or inflammatory reaction (33). 
 
Histopathology  
From a histological perspective, the JNA cells are observed to be of myofibroblast origin 
and are surrounded by a fibrous pseudocapsule.  Within the neoplasm there is a 
distribution of multiple vascular channels of abundant endothelial cells that are embedded 
within a collagenous tissue network. The characteristics of JNA reveal an absence of a 




                                                                                     
Diagnosis of JNA could be based on a patient presenting with the following symptoms: 
• A  nasal mass of reddish or purplish colour that is smooth and lobulated  
• A large tumour burden linked to massive haemorrhage 
• Facial swelling or proptosis that could indicate progression of tumour 
• Dacryocystitis when anterior extension could obstruct the nasolacrimal duct in 
advanced tumours 
• Recurrent nasal bleeding or epistaxis in adolescent males  
FiFfg 
23 
• Unilateral nasal obstruction  
• Atypical symptoms such as anosmia, hyposmia, palatal deformity, rhinolalia, and 
blockage of the eustachian tubes with middle ear effusions and conductive 
hearing loss 
 
Submucosal extension is characteristic of JNA and the tumour can spread towards the 
superior orbital fissure, infratemporal fossa or the pterygomaxillary fossa (35), and in 
20% to 36% of cases intracranial extension occurs within the pituitary parasellar region 
or the anterior or middle cranial fossae region (36). 
 
Successful treatment requires complete surgical excision; 46% of incomplete resections 
will result in recurrence of the tumour (37). There is a high risk of tumour extension to 
the clivus, pterygoid base and sphenoid sinus. A review of the literature reveals patients 
over the age of 25years can demonstrate spontaneous regression, which could be 





• Olfactory neuroblastoma 




• Nasal polyps 
• Hemangiopericytoma 





In 1981, Sessions first classified JNA, but since that time, various modifications have 
been included by Andrews (1989), Chandler (1984) and Fisch (1983). Radkowski most 
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recently introduced and adapted the staging system based on the degree of skull base 
erosion and the tendency of JNA to extend posteriorly to the pterygoid plates (39). 





Stage                                               Features 
1A Tumour only identified in posterior nares and/or nasopharyngeal vault 
 
1B Tumour identified in posterior nares and/or nasopharyngeal vault with at least 1 
paranasal sinus involved 
2A Minimal lateral extension into pterygomaxillary fossa 
 
2B Pterygomaxillary fossa fully occupied with or without superior erosion of orbital 
bones 
3A Skull base erosion 
Minimal intracranial extension  
3B 
 









                                                 Features 
 
I.  Tumours only identified in nasal cavity, nasopharynx with no bony destruction  
 
II.  Tumours have invaded pterygomaxillary fossa, paranasal sinuses with bony 
destruction 
III.  Tumours have invaded infratemporal fossa, orbit and/or parasellar region 
remaining lateral to cavernous sinus. 






 A computed tomography (CT) scan can reveal the characteristic features of JNA, and 
diagnosis of JNA is supported by the lack of regional or distant metastasis. JNA exhibits 
characteristic features on CT scan as the presence of bony modelling with tumour growth, 
and the presence of a vascular mass with an epicentre at the posterior nasal cavity.  
CT imaging is superior when compared to magnetic resonance imaging (MRI) in terms of 
evaluating bony details. JNA is normally associated with anterior bowing of the posterior 
maxillary sinus wall, known as the Holman-Miller sign. CT scans can also reveal 
widening of the sphenopalatine foramen, but the degree of intracranial extension is better 
assessed by MRI scans. To identify the source vessels, and for preoperative embolization, 
angiography is critical. Embolization is considered effective to reduce intraoperative 
blood loss and should be done 24 to 72 hours prior to surgical resection (40, 41, 42). 









CT showed an intensely enhancing mass in 
sphenopalatine region 
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Surgery for JNA 
Surgical excision is the main treatment modality (43) and endoscopic resection of JNA 
has attracted significant interest. To gain adequate exposure and to dissect around the 
tumour, a middle turbinectomy, posterior septectomy and wide middle meatal antrostomy 
is often required. The sphenopalatine artery is often within the tumour bulk but removing 
the posterior maxillary sinus wall can expose this area. Denker’s approach can enable 
access laterally to lesions involving the infratemporal fossa. A diode handheld laser is 
useful to perform extracapsular tumour dissection, especially from the pterygopalatine 
and infratemporal fossas.  
 
Transnasal endoscopic approaches offer various benefits, such as better postoperative 
surgical morbidity without outcome being compromised. Endoscopic approaches do 
present important limitations, such as bleeding, with exposure often being difficult due to 
tumour bulk. Blood loss can be managed by applying two methods during endoscopic 







JNA visible on nasal endoscopy 
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Surgical approaches for many tumours are often limited by blood loss, exposure and risk 
to vital anatomical structures; therefore, the standard of care for certain skull base 
tumours has become endoscopic transnasal resection. Other surgical fields often use cell 
salvage techniques, but review of the otolaryngology literature to discover the benefits of 
these techniques, reveal very few case reports.  In general surgery, cell salvage is carried 
out in a contaminated field and concerns have been raised about its safety.        
 
This study investigated the value and safety of salvage-type autologous blood transfusion 
during the endoscopic resection of juvenile nasopharyngeal angiofibromas (JNA). 
 
Methods 
JNA is a rare vascular nasal tumour and the study extended over a 3-year period to obtain 
adequate patient numbers. All patients undergoing endoscopic resection during this 
period were included in the population sample. Ten patients with JNA were identified 
and underwent embolization prior to the endoscopic resection. In all cases the 




Homologous blood transfusion could be avoided in all cases. Postoperative monitoring 
revealed transient bacteraemia in two cases where the leukocyte filter was not used, but 
no evidence of septicaemia.  
 
Conclusions  
Perioperative cell saver and autologous blood transfusion in endonasal JNA surgery is 
safe. Homologous blood transfusion can be avoided by using this technique. The use of 
cell salvage allows for single stage surgery without the need to abandon surgery due to 




For more than 25 years, trauma, orthopaedic, urological, liver transplant and cardiac 
surgery have used intraoperative cell salvage (PCS) techniques (1). However, in 
contaminated surgical fields the role of cell salvage techniques has been contentious. 
Contaminated surgical fields have been previously considered as a relative or absolute 
contraindication for intraoperative cell salvage. A review of the literature reveals no 
research about the utilisation of cell salvage techniques in endonasal surgery. 
 
Tumour surgery often results in the need for intraoperative allogeneic blood transfusion 
due to heavy blood loss. Many reports have focused on allogeneic transfusion risks, such 
as immunomodulation and infection.	   During juvenile nasopharyngeal angiofibroma 
(JNA) surgery, severe intraoperative bleeding can occur and preoperative embolization is 
useful to keep bleeding to a minimum.  Intraoperative cell salvage blood transfusion can 
be used to avoid the use of allogeneic blood transfusion, thereby minimising the risk of 
developing transfusion complications. 
 
The autologous red cell recovery system, also known as the “cell saver”, has a double 
lumen tube that mixes the aspirated blood with a heparin solution and collects it in a 
reservoir (Figure 1). A centrifuge is then used to separate erythrocytes from the blood 
and cell stroma, free haemoglobin and plasma flow to the waste bag. The leukocyte filter 
is used to provide further protection, and blood is then re-infused into the patient 
(figure1). The mechanisms of leukocyte reduction by leukocyte depletion filter (LDF) are 
insufficiently understood, but it is widely accepted that centrifugal effects are the 
mechanisms to eliminate bacteria with cell saver methods. Bacterial removal mechanisms 
of the leukocyte depletion filter (LDF) cannot depend on the size of bacteria alone, but 
would be more dependent on adhesive characteristics of the filter, such as the surface 
structure of the material used in the filter, wettability, surface charge, the disintegration of 
cells and deformability of infected cells in the filter (2,3).  
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Figure 1: Cell salvage techniques 
 
 
Centrifugal effects are used to eliminate bacteria with cell saver techniques, but there is 
insufficient understanding of the precise mechanisms of leukocyte elimination by 
leukocyte depletion filter (LDF). Reports indicate that 97.6% to 100% of bacterial 
colony-forming units could be cleared when blood is subjected to a leukocyte filtration 
system and is washed. 
 
Cell salvage can eliminate or reduce the need for allogeneic blood transfusions and avoid 
the infectious and non-infectious complications that occur after transfusions. A review of 
the literature shows that cell salvage is effective in reducing allogeneic blood transfusion 
requirements during adult elective surgery. Based on evidence gleaned from cardiac and 
orthopaedic surgery, it is safe and effective. Recent reports indicate that cell salvage is 
increasingly used during trauma surgery even though the surgical field is often deemed 
contaminated. All reports relating to trauma surgery have found cell salvage to be a safe 
technique that avoids allogeneic blood transfusion.  
 
According to our reading, there has been no research done with regards to the role of red 
cell salvage in endoscopic JNA surgery. This research forms a preliminary study into the 
role of cell salvage during JNA surgery. 
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MATERIAL AND METHODS 
 
The Human Research Ethics Committee of the University of Cape Town approved the 
prospective study. The study included all patients undergoing endoscopic resection of 
JNA at Groote Schuur Hospital and Panorama Mediclinic.  Ten patients were included; 
they all underwent pre-operative embolization, had intra-operative cell salvage and close 
postoperative monitoring.  
 
Patients scheduled for elective endoscopic transnasal resection of a JNA were included in 
the population sample if the estimated blood loss was more than 500ml and they would 
qualify for intraoperative blood transfusion. Exclusion criteria included patients who bled 
minimally intraoperative and did not require blood transfusion.  
 
Patients were all male and aged between 12 and 20 years (Figure 2).  One patient was a 
Jehovah’s Witness and allogeneic blood transfusion was therefore not allowed. 
Autologous blood transfusion via a salvage system was acceptable to the Jehovah’s 
Witness group if intraoperative blood transfusion was required.  
 
  
Figure 2: Age distribution  
 
Based on the Fisch staging system for JNA, 6 patients had stage 2 tumours and 4 had 
stage 3 tumours (Table 1, Figures 3 & 4). Two patients had staged procedures with initial 
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incomplete resection and the rest of the sample population had successful complete 
resection of the tumour at the first surgery. 
 




Figure 3: CT showing stage 3 JNA 
An intra-operative nasal swab was taken to determine the presence of bacteria and to 
obtain sensitivities in the event that antibiotics were required postoperatively. The cell 
saver system was used to salvage autologous blood. A second specimen for MCS was 
taken from the cell saver system to detect the presence of organisms in the autologous 
blood that was to be transfused back to the patient. 
 
The anaesthetist and surgeon based decisions to transfuse each patient on their 
haematocrit and clinical stability. Blood was collected from the cell saver unit by the 
technician and all patients received autologous blood instead of allogeneic blood. 
6 patients Stage 2 Tumours invading pterygomaxillary fossa, paranasal sinuses with 
bony destruction 
4 patients  Stage 3 Tumours invading infratemporal fossa, orbit and/or parasellar 
region remaining lateral to cavernous sinus 
 




Washed, concentrated red blood cells (RBC) were returned to the patients. All patients 
received prophylactic intraoperative antibiotics and a post-operative course of broad 
spectrum antibiotics. Patients were monitored for signs of infection / septicaemia by 
routine methods such as temperature and pulse rate. A blood culture was performed one 
day following surgery to exclude a bacteraemia or septicaemia. 




The study included 10 patients scheduled for elective endoscopic transnasal resection of a 
JNA, whose estimated intraoperative blood loss was more than 500 mL and required 
blood transfusion. All patients had cell saver blood transfusions based on their 
intraoperative clinical stability and blood investigations. The volume of blood re-infused 
as a percentage of the volume lost is an underestimate because the blood lost is diluted 
and the re-infused blood has a high haematocrit, usually more than 50%, therefore 
allowing adequate transfusion. The mean volume of blood lost from the 10 patients was 
1530 mL (500ml-4000ml). The mean volume of re-infused blood was 875 mL (200 ml-
2600 ml) (Figure 5). 
 
 
Figure 5: Intraoperative blood loss and perioperative cell salvage blood transfusions 
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In order to evaluate whether the operative field was contaminated or not, nasal swabs 
were taken from the prepared surgical field just before the resection of the tumour. 
Bacterial growth was detected in all specimens. Organisms that were cultured included: 
Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus viridans, and 
Moreaxella catarrhalis (Table 3). 
 





Methicillin resistant Staphylococcus aureus (MRSA) 1 
Staphylococcus epidermidis 1 
Streptococcus viridans 2 
Moraxella catarrhalis 1 
 
Table 3: Microbiologic results of swabs of the nasal cavity 
 
All patients received intraoperative antibiotics and an intravenous postoperative course of 
broad spectrum antibiotics. Routine methods were adopted to monitor patients 
postoperatively for any sign of infection, such as temperature and pulse rate.  A blood 
culture was performed on the day following the operation. 
 
The leukocyte filter was not used in two cases, as it was not available in the state hospital 
at that time. In both of them, the same organism that was isolated from the nasal cavity 
was also cultured from the cell saver washed blood. Postoperatively they developed a 
transient bacteraemia with a raised temperature and pulse rate and a positive blood 
culture. In both cases the same organism was cultured from the operative field and post-
operative blood culture (Table 4). Both were treated with the appropriate IV antibiotics 





















blood	  culture	  	  	  
Patient	  1	  
	  
500	  	  ml	   200	  	  	  ml	   Staphylococcus	  
Aureus	  
No	  Growth	   No	  Growth	  
Patient	  2	  
	  
500	  	  	  ml	   300	  	  ml	   Staphylococcus	  
Aureus	  
No	  Growth	   No	  Growth	  
Patient	  3	  
	  
1700	  ml	   700	  	  ml	   Staphylococcus	  
Aureus	  
No	  growth	   No	  Growth	  
Patient	  4	  
No	  LDF	  









4000	  ml	   2500	  ml	   Streptococcus	  
Viridans	  
No	  Growth	   No	  Growth	  
Patient	  6	   3000	  ml	   1700	  ml	   Methicillinresistant	  
Staphylococcus	  
Aureus	  (MRSA)	  
No	  Growth	   No	  Growth	  
Patient	  7	   1000	  ml	   600	  	  	  ml	   Staphylococcus	  
Epidermidis	  
No	  Growth	   No	  Growth	  
Patient	  8	  
	  
900	  	  	  ml	   400	  	  	  ml	   Streptococcus	  
Viridans	  
No	  Growth	   No	  Growth	  
Patient	  9	  
	  
1000	  ml	   600	  	  	  ml	   Moraxella	  
Catarrhalis	  
No	  Growth	   No	  Growth	  
Patient	  10	  
No	  LDF	  







Table 4: Summary of results  
 
 
Postoperatively, all patients in this study were admitted to the intensive care unit for one 
day for monitoring.  Laboratory coagulation tests were taken on arrival in the ICU, and 
the mean INR (international normalised ratio) in the control group was 1.1. None of the 
patients had postoperative epistaxis or any evidence of coagulopathy. 
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Routine postoperative monitoring revealed that haemoglobin and coagulation levels were 
within the normal range for all patients, with no evidence of major complications such as 
haemoglobinuria, coagulopathy, cardiopulmonary issues and major sepsis (Figure 6). 
None of the patients required any allogeneic blood products. Regular follow up after 
discharge showed no adverse events. 
 
Figure 6: Routine post-operative temperature monitoring 
 
The mean hospital stay for all patients was 3 days. Nasal packs were removed on the 
second day after surgery and no patients were required to return to the theatre for 
haemostasis.  All patients were seen in the clinic 7 days after surgery for routine 
endoscopic examination and nasal debridement. Yearly follow up was planned for all 
patients. 
 
DISCUSSION AND CONCLUSIONS 
 
Earlier literature did not recommend the use of cell saver techniques in contaminated 
surgery.  There has been insufficient research regarding the use of cell salvage during 
transnasal endoscopic surgery for benign vascular tumours (1). However, for the past 25 
years, intraoperative cell salvage techniques have been used in trauma, orthopaedic, 
urological, liver transplant and cardiac surgery (1). 
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The most common benign vascular neoplasm of the nasopharynx is juvenile 
angiofibroma (JNA) (2). It has locally destructive growth features and cause bony erosion 
despite its benign histology. JNA can extend intracranially and cause complications that 
are potentially life threatening, such as intraoperative massive blood loss and fatal 
epistaxis (2). There are fibrotic and vascular elements within these tumours, but as the 
vessels lack elastic lamina and elastic fibres, they are unable to contract which may result 
in significant blood loss during surgical resection (3, 4). The management of JNA can be 
challenging because of its aggressive growth pattern, complex adjacent anatomical vital 
structures and rich vascular supply. 
 
Our institute uses two methods to control blood loss during JNA surgery: the first method 
is preoperative embolization which was performed in all our patients. The second method 
is intraoperative cell salvage technique. 
 
A review of the literature indicates that cell salvage techniques could be used in routine 
surgery when the patient has significant red blood cell antibodies, is a member of the 
Jehovah’s Witness religious group or when significant blood loss is anticipated (over 
1000 mL) (5). There are many advantages when using intraoperative cell salvage 
techniques, such as for Jehovah Witness patients who usually accept this form of blood 
transfusion, reduced burdens on blood donation systems, the blood available is 
proportional to the blood lost during surgery, haemodilution is not caused, and it can be 
used when significant blood loss is anticipated (6). Salvaged red cells also have a better 
oxygen delivery profile, and the system is cost-effective.  
 
Intraoperative cell salvage autologous transfusion can avoid complications such as end 
organ injury, immunosuppression, volume overload, graft versus host disease and allergic 
and febrile reactions. Findings from previous studies indicate that allogeneic blood 
transfusion can be associated with increased mortality, myocardial infarction and 
increased risk of tumour recurrence (7).  
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It is widely accepted that the use of the leukocyte depletion filter and centrifugal effects 
in cell saver techniques removes bacteria, and previous reports indicate that 97.6% to 
100% of bacterial colony-forming units can be cleared when blood is subjected to the 
leukocyte filtration system and is washed. 
          
Timberlake and McSwan (1988) studied cell saver techniques and suggested that for 
gastrointestinal perforation patients, cell saver blood could be used when no banked 
blood is available as long as broad spectrum antibiotic prophylaxis is given. The findings 
from this study explained that from 11 patients with enteric contaminated blood, 3 of 
these had an infectious wound complication. It most likely included a nosocomial 
complication from the intensive care unit, but this study reported no deaths (8). 
 
Kang et al. (1991) studied 14 patients undergoing liver transplant surgery and found 
positive cultures in the re-transfusion bag in 8 of 28 samples. Infections were not 
observed in this study, and after 1 week the cultures taken from patients had remained 
sterile (9). 
 
Other surgical fields have also demonstrated the successful use of culture-positive cell 
saver blood.  A Japanese study looked at cell salvage autologous transfusions over a 2-
year period Samples of salvaged blood were taken before re-infusion and findings 
revealed one third of all samples were culture positive (10).	   Ezzedine et al. (11) 
discovered an infection incidence of 12.7% from cultured samples of salvaged blood 
from every case that required autologous transfusion. Locher and Sailer (12) studied 
salvage autologous transfusion in maxillofacial surgery and revealed that most patients 
had received between 1 and 10 million organisms in each blood volume re-transfused. All 
these previous studies reported that no adverse clinical consequences occurred when the 
contaminated blood was given.  
 
Another concern associated with cell salvage blood is the promotion of coagulopathy, but 
no evidence of coagulopathy was revealed in all patients, and all laboratory parameters 
were normal.  
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The use of cell salvage autologous blood transfusion has clearly indicated its cost 
effectiveness, as allogeneic blood products were avoided for all patients. However, the 
cost of leukocyte filters should be a consideration when comparing allogeneic blood 
products, although these filters are not expensive. The issue of cell salvage costs is 
important, and most research studies have found that the financial benefits of autologous 
transfusion are significant, such as shorter hospital stay, reduced blood transfusion 
reactions, reduced postoperative infection rates, and reduction in allogeneic blood 
transfusion. However, there is a need to compare the comparative costs of cell salvage 
blood transfusion and allogeneic blood transfusion in a randomised controlled study.  
 
This institute reduces the costs of cell salvage by using this standby technique in every 
JNA case, which includes collecting blood from the operative field. Heparin is added to 
the collected blood, and only processed if a sufficient volume is recovered, or if the 
patient requires blood transfusion. The disposables and the leukocyte filter need only be 
set up when a decision to process the blood is made. We found that using the standby 
technique reduced the costs of cell salvage by 90% if no blood was processed.  
  
Our study has shown that cell saver techniques are beneficial in JNA surgery, as the 
surgery can be completed in one stage and there is a decreased need for allogeneic blood 
transfusion, and is often acceptable to Jehovah’s Witness patients, as an alternative to 
allogeneic blood transfusion. This study has also demonstrated that intraoperative cell 
salvage is a safe technique in endoscopic JNA surgery. It is however important to use 
leucocyte depletion filters and intraoperative and postoperative broad spectrum 
antibiotics. These findings indicate that when bacteria are introduced with the re-
transfused blood, the intact immunological system adapts to protect patients against a 
number of commensal micro-organisms. This explains the good tolerance to the 
iatrogenic bacteraemia that was caused.  
 
The combination of washing blood cells and using a leucocyte filter significantly reduced 
the bacterial load in processed blood that could then be safely re-transfused to the patient. 
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Leukocyte depletion filters have been widely used during the processing of donated blood 
to remove white blood cells and their use is now acknowledged to improve cell salvage 
safety and to reduce the incidence of any cell salvage adverse effects (13). Various 
findings have revealed that leukocyte depletion filters are effective in removing white 
blood cells, tumour cells, (14, 15, 16) amniotic fluid, (17) and bacteria (18). 
 
In conclusion, cell salvage autologous blood transfusion is safe and effective in reducing 
allogeneic blood transfusion	   requirements in endoscopic JNA surgery. Cell salvage 
should be considered in all cases of JNA surgery as significant blood loss is usually 
anticipated. This can also be used in situations when patients refuse allogeneic blood 
products.	   The standby technique allows cell salvage to be used in cases where blood 
transfusion is not required, but significant bleeding is a possibility, which contributes to 
greater reduction in allogeneic blood transfusion requirements.	   Leukocyte depletion 
filters are recommended to provide an additional element of safety, and should be used in 
all cell salvage autologous blood transfusions. In addition, a contaminated surgical field 
is not a contraindication for the use of cell salvage blood as long as adequate precautions 
are taken.	   Recent evidence has shown that cell salvage may be used in malignancy 
surgery, and that the only contraindication to using cell salvage blood, is the patient’s 
refusal to accept autologous blood.  
 
Although the use of intraoperative cell salvage in combination with a leukocyte depletion 
filter appears to be safe in endoscopic JNA surgery, further research is needed with a 
larger population sample to define the efficacy of this technique in saving allogeneic 





Written informed consent was obtained from the patients and their parents for publication 
of this case report and accompanying images. A copy of the written consent is available 
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